Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rena Buckstein

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
The Lancet. Haematology|February 2, 2019
Eltrombopag use in higher risk myeloid cancers: fitting a square "pag" into a round hole?Rena Buckstein
The Lancet. Haematology|July 21, 2024
SintraREViewed: practice changing, or validation required?Rena Buckstein
The Lancet. Haematology|December 22, 2015
Eltrombopag in patients with high-risk myelodysplastic syndrome or acute myeloid leukaemia: cautious optimismRena Buckstein
Transfusion|June 5, 2019
Outpatient transfusions: time to study what matters to patientsYulia Lin, Rena Buckstein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2014
Myelodysplastic syndrome successfully treated with adalimumabAnca Prica, Rena Buckstein
Haematologica|June 26, 2025
Should we move past erythropoietin-stimulating agent monotherapy in lower-risk myelodysplastic syndromes?Lee Mozessohn, Rena Buckstein
Leukemia & Lymphoma|August 23, 2008
Paraneoplastic lumbosacral axonal polyradiculopathy preceding the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma: a case reportSarah Ingber, Rena Buckstein
Hematology. American Society of Hematology. Education Program|December 5, 2025
Management of iron overload in adult myelodysplastic syndromeHeather A Leitch, Rena Buckstein
Blood|June 28, 2024
How I treat iron overload in adult MDSHeather A Leitch, Rena Buckstein
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic SyndromesGregory A Abel, Rena Buckstein
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
The Lancet. Haematology|February 2, 2019
Eltrombopag use in higher risk myeloid cancers: fitting a square "pag" into a round hole?Rena Buckstein
The Lancet. Haematology|July 21, 2024
SintraREViewed: practice changing, or validation required?Rena Buckstein
The Lancet. Haematology|December 22, 2015
Eltrombopag in patients with high-risk myelodysplastic syndrome or acute myeloid leukaemia: cautious optimismRena Buckstein
Transfusion|June 5, 2019
Outpatient transfusions: time to study what matters to patientsYulia Lin, Rena Buckstein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2014
Myelodysplastic syndrome successfully treated with adalimumabAnca Prica, Rena Buckstein
Haematologica|June 26, 2025
Should we move past erythropoietin-stimulating agent monotherapy in lower-risk myelodysplastic syndromes?Lee Mozessohn, Rena Buckstein
Leukemia & Lymphoma|August 23, 2008
Paraneoplastic lumbosacral axonal polyradiculopathy preceding the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma: a case reportSarah Ingber, Rena Buckstein
Hematology. American Society of Hematology. Education Program|December 5, 2025
Management of iron overload in adult myelodysplastic syndromeHeather A Leitch, Rena Buckstein
Blood|June 28, 2024
How I treat iron overload in adult MDSHeather A Leitch, Rena Buckstein
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic SyndromesGregory A Abel, Rena Buckstein
Pageof 14